Moderna, Inc. MRNA

Dow 1000 points take that you fuck face tariff prick 😂😂😂😂😂

One potential longer-term tailwind for Iovance that deserves investor attention is California’s proposed $8.4 billion Proposition 38 bond measure. It includes $4.2 billion for a UCLA-affiliated immunology and immunotherapy research institute and another $4.2 billion for competitive research grants.

While Iovance would not qualify for direct grants as a for-profit company, the funding could create opportunities for academic partnerships, TIL research, clinical trial infrastructure and collaboration with commercial cell-therapy developers.

Given Iovance’s existing California clinical trial footprint and its leadership in tumor-infiltrating lymphocyte (TIL) therapy, the scientific alignment is particularly interesting.

https://www.foxnews.com/video/6407639589112

Back to -15% for sure :)

Timber....

Heading to $150 this week.

Dropped -10% still in green :)

This stock worth 30 dollars

Open 6% down still buying it???

Moderna will become a great company in 5/10 years, but it is not at this time. My short term target price is $135 says the Almighty